Ev Pharma Solutions Ltd
09984833
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/04/2025
micro entity
Next accounts due
31/01/2027
Confirmation statement
Last: 02/02/2026
Due 16/02/2027
Industry
Officers
director · Since 03/02/2016
DIRECTOR
GREEK · UNITED KINGDOM · Age 54
Also on 1 other board
Persons with Significant Control
Ms Evgenia Mengou
Greek · United Kingdom · Age 54
Second Floor, Kirkland House, 11-15 Peterborough Road, Harrow, HA1 2AX
Notified 06/04/2016
CompanyRankvs 8090+ SIC 74909 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/04/2025
Net Worth
£477k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£455k
Working capital
Current Assets
£498k
Current Liabilities
£42k
Fixed Assets
£22k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 11.72 | -£11k |
| 2024 | 16.09 | -£121k |
| 2023 | 12.12 | +£95k |
| 2022 | 8.10 | +£176k |
| 2021 | 4.34 | +£189k |
| 2020 | 3.43 | +£106k |
| 2019 | 4.54 | — |
Derived from filed accounts. Not audited figures.